article thumbnail

Novel Approaches in Cancer Immunotherapy — Featuring OncoC4 founder, CEO and CSO Dr. Yang Liu and CFO Abid Ansari – Xtalks Life Science Podcast Ep. 146

XTalks

OncoImmune was founded in 2000 based on the scientific discoveries of the company’s founders who moved their lead product from a basic concept into clinical trials for multiple indications. Subscribe to the Xtalks Life Science Podcast to never miss a new episode.

article thumbnail

eClinical Provider Crucial Data Solutions Appoints Brian Dufresne as SVP Business Development

Crucial Data Soutions

After experiencing significant growth in the clinical trial solutions market in 2021, Crucial Data Solutions has added another industry veteran to its leadership team. Founded in 2010, Crucial Data Solutions (CDS) provides the most innovative low-code/no-code data and clinical trial management technology on the market today.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Interview with Cody Simmons, CEO of DermaSensor, Maker of Handheld Skin Cancer Evaluation Tool – Xtalks Life Science Podcast Ep. 107

XTalks

He began his career in business development and commercial strategy roles at Genentech. Subscribe to the Xtalks Life Science Podcast to never miss a new episode. Cody Simmons, CEO, DermaSensor As a bioengineer and entrepreneur, Cody has spent all of his career bringing new health technologies to physicians and patients.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharmaceutical companies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. Gareth Powell is a business development officer for the NIHR Clinical Research Network (CRN).

article thumbnail

Synthetic control arms in clinical trials: Making it happen

pharmaphorum

Across the industry, pharma companies are turning to AI and real-world data to address many of the challenges of running clinical trials. Can the combined potential of new AI technologies and real-world patient data hold the key to overcoming the challenges in clinical trial design that have historically led to trial failure?

article thumbnail

Neumora raises funds for precision neuro therapies development

Pharmaceutical Technology

New and existing investors including F-Prime Capital, Altitude Life Science Ventures, Mubadala Capital, Amgen, Exor Ventures, ARCH Venture Partners, Invus, Abu Dhabi Growth Fund (ADG), Newpath Partners, Polaris Partners, as well as other undisclosed investors have participated in the financing round.

article thumbnail

Increasing patient engagement with UK clinical trials

pharmaphorum

Pharma companies face many challenges when involving patients in the design of clinical trials – but doing so can have huge benefits further down the line, improving the sustainability and quality of research. Involving patients in discussions.